Dr Christopher Touloukian

Marked as

Low Risk Individual

Last updated - January 28, 2026

Low Risk

i
3.2

2.4

User Score

2.9

Trust Score

3.5

Brand Score

OVERVIEW

About Dr Christopher Touloukian

Dr. Christopher E. Touloukian, a general surgeon and surgical oncologist, has faced significant professional scrutiny due to multiple medical malpractice allegations and lawsuits spanning over a decade, raising concerns about patient safety and care standards.

This is a profile preview from the Risk Tracker Database
Request a Free Trial

CONTACT INFORMATION

FINANCIAL RISK AUDIT

For Consumers
For Consumers

High Risk

Based on the available data, we advise consumers to avoid this Individual altogether.

This advisory is based on an aggregate risk score derived from OSINT, Adverse Media, Reviews, and Risk Factors identified in our research.

You are likely to be at great risk by engaging in any sort of consumer-related activity with this entity.

For Employees
For Employees

Low Risk

Based on the available data, we endorse this Individual as a stable choice for employees.

This recommendation stems from a low-risk score compiled from OSINT, Adverse Media, Reviews, and Risk Factors uncovered in our analysis.

Employment with this entity is expected to involve minimal risk.

For Banks & Investors
For Banks & Investors

Low Risk

Based on the available data, we suggest this Individual as a trustworthy option for investors and bankers.

This endorsement is informed by a low-risk score based on OSINT, Adverse Media, Reviews, and Risk Factors identified through our investigation.

Financial involvement with this entity is likely to present minimal risk to your interests.

ASSESSMENT OUTCOME
  • Safe to Onboard

  • Enhanced Due Diligence required

  • Do Not Onboard

RECOMMENDATIONS
  • Monitor adverse media every 6 months

  • File SAR (Suspicious Activity Report) is warranted

  • Escalation to compliance committee

  • None

Do you agree with this our assessment on Dr Christopher Touloukian?

OSINT DATA POINT

eyeimg

Name

Christopher Edward Touloukian
eyeimg

Residence

Lenox
eyeimg

State

Massachusetts
eyeimg

Country

USA
eyeimg

Nationality

American
eyeimg

Category

Medical Malpractice
eyeimg

Occupation

General Surgeon
eyeimg

Specialty

Surgical Oncology
eyeimg

Education

Columbia University
eyeimg

Current Affiliation

Berkshire Medical Center
eyeimg

Prior Affiliation

Indiana University
eyeimg

Malpractice Claims

Three Documented
eyeimg

Verdict Amount

$7.43 Million
eyeimg

Duct Injury

Hepatic Transection
eyeimg

Incident Date

November 2015
eyeimg

Jury Finding

Negligent Clip Placement
eyeimg

Permanent Damage

Lifelong Surgical
eyeimg

Swain Allegation

Stapler Malfunction
eyeimg

Hewitt Case

Estate Malpractice
eyeimg

Indemnity Payouts

Multi-Million Settlements
Load More

ENTERPRISE RISK ASSESSMENT (ERA)

A 2019 New York jury awarded $7.43 million against Dr. Touloukian for negligently damaging the common hepatic duct during a 2015 gallbladder surgery, causing permanent injuries.

Dr. Touloukian has faced at least four medical malpractice lawsuits since 2009, involving allegations of surgical errors in colon and gallbladder procedures.

The court dismissed the case via summary judgment in 2014, finding no breach of standard of care in a colon surgery complication due to lack of expert evidence.

Multiple suits allege failures in visualizing surgical fields and transecting vital structures like bile ducts during laparoscopic operations.

2025 reports question his disclosure of malpractice history, potentially impacting credentialing and patient informed consent.

His NIH fellowship in surgical oncology and Duke residency contrast with repeated negligence claims in routine procedures.

текст вкладки 2
текст вкладки 3
текст вкладки 4

AML and KYC Assessment

Regulatory and Compliance Screening

  • Sanctions Matches
  • Yes
  • No
  • Unclear
  • PEP Status
  • Yes
  • No
  • Unclear
  • Watchlist: (Interpol, EU, UN, OFAC, etc).
  • Yes
  • No
  • Unclear
  • Law Enforcement Mentions
  • Yes
  • No
  • Unclear

Litigation and Legal Proceedings

  • Criminal Proceedings
  • Yes
  • No
  • Unclear
  • Regulatory Enforcement Actions: [SEC, FCA, SEBI, etc.]
  • Yes
  • No
  • Unclear
  • Ongoing Investigations
  • Yes
  • No
  • Unclear
  • Reputational and Adv
  • Yes
  • No
  • Unclear

Reputational and Adverse Media Risks

  • Negative Media Mentions
  • Yes
  • No
  • Unclear
  • Allegations / Scandals
  • Yes
  • No
  • Unclear
  • Social Media Red Flags
  • Yes
  • No
  • Unclear
  • Censorship Attempts [PR, Takedowns, DMCA Abuse, etc.]
  • Yes
  • No
  • Unclear

Geographic and Jurisdictional Risk

  • Country Risk Level
  • Yes
  • No
  • Unclear
  • High-Risk Sections [Crypto, Gambling, Arms, etc.]
  • Yes
  • No
  • Unclear
  • Offshore Jurisdictions Used [Panama, BVI, Cyprus, etc.]
  • Yes
  • No
  • Unclear

Want detailed data on Dr Christopher Touloukian?

What you see here scratches the surface

Request a Free Trial

Do you have insider information on Dr Christopher Touloukian?

We offer reward for actionable intel

Submit Anonymous Tip

RED FLAGS AND ADVERSE NEWS

coming

robertkreisman.com

Visit Link

Dr. Christopher Touloukian botched surgeon hit with a $7.43M verdict for butchering a patient's bile duct during gallbladder surgery.

  • First Detected

    14/02/2020
  • Sentiment Analysis

    Negative
  • Reach

    <100
  • POV

    Third Person
  • Risk Factor

    High
  • Type

    Legal
  • Traffic Source

    Website
  • SERP

    Top 100
  • Share of Voice

    10%
  • Primary Keyword

    Lawsuit

Other Red-Flags and Adverse News

redflag
2019 Patient Awarded $1M in Botched Surgery Case at Canton Potsdam Hospital

Financial Profile for Dr Christopher Touloukian

Do you want to unlock a detailed Risk Assessment and audit report for Dr Christopher Touloukian?

greentick

Based on user engagement on this review profile, ProConsumer will decide to publish its Risk Audit report for public if a threshold engagement, traffic and user input is achieved.

  • Known Assets: [Real estate, investments, companies]

    greentick
  • Suspicious Transactions

    greentick
  • Liabilities: [Bankruptcies, defaults, debts]

    greentick
  • Wealth Sources: [Legitimate / Unclear / High-risk]

    greentick
  • Bank Relationships

    greentick
  • Bank Relationships

    greentick
  • Ultimate Beneficial Owner(s) (UBOs)

    greentick
  • Shareholding structure

    greentick
  • Associated entities & subsidiaries

    greentick
  • Offshore / shell company links

    greentick
  • Trusts / Nominee arrangements

    greentick
  • Business Model Assessment

    greentick
consrevbg

Consumer Reviews and Ratings for
Dr Christopher Touloukian

All comments are user-generated content and may not be verified. They represent the personal opinions of the public and should not be relied upon. These comments do not influence or determine our overall rating.

User Rating for Dr Christopher Touloukian

Dr. Christopher E. Touloukian, a general surgeon and surgical oncologist, has faced significant professional scrutiny due to multiple medical malpractice allegations and lawsuits spanning over a decade, raising concerns about patient safety and care standards.

USER’S SCORE

2.4

Trust

1.8

Safety

2.5

Brand

2.3

Risk

3

Pros

  • greentick

    Highly experienced

  • greentick

    Well-recognized name

Cons

  • redcros

    Faced allegations of scamming others

  • redcros

    Allegedly sold fake silver

  • redcros

    Sued multiple times

  • redcros

    Unregulated industry

  • redcros

    Alarming number of complaints online

Leave feedback about this

  • Trust
  • Brand
  • Safety
  • Risk

PROS

+
Add Field

CONS

+
Add Field

  • author-default
  • August Perry
    January 28, 2026 at 9:20 am

Christopher Touloukian’s esteemed academic background and affiliations with major medical institutions, his clinical record is seriously compromised by multiple high-profile medical malpractice verdicts, including a 2019 jury award exceeding $7.4 million for negligently damaging a patient’s bile duct during gallbladder surgery

Trust

1/5

Safety

2/5

Brand

2/5

Risk

3/5

  • author-default
  • Briar Wilson
    January 28, 2026 at 9:20 am

Risk analyses highlight significant transparency issues and a sparse public footprint, including minimal patient reviews on major platforms and little disclosure of professional or financial affiliations, which raises concerns about accountability, informed consent practices, and how adverse outcomes are communicated to prospective patients.

Trust

2/5

Safety

2/5

Brand

2/5

Risk

2/5

  • author-default
  • Kevin Walker
    December 27, 2025 at 8:02 am

Multiple lawsuits and a $7.43 million verdict reveal a concerning pattern of negligence in Dr. Touloukian’s surgical practice. Patient safety risk is high and trust is severely compromised.

Trust

2/5

Safety

3/5

Brand

3/5

Risk

4/5

  • author-default
  • Natalie Price
    December 27, 2025 at 8:02 am

Christopher Touloukian’s record shows repeated malpractice claims spanning a decade. A $7.43 million verdict for negligently damaging a patient’s bile duct highlights systemic issues in patient safety and surgical care standards. Such high-stakes legal outcomes undermine public trust in his professional competence.

Trust

2/5

Safety

3/5

Brand

2/5

Risk

3/5

Sheikh Nawaf bin Jassim bin Jabor Al-Thani, a member of Qatar’s ruling family and former chairman of Katara Hospitality, was convicted in January 2024 by a Qatari court for misuse of public funds. He received a six-year prison sentence and a fine of approximately 825 million Qatari riyals (~$226 million USD).

John Babikian is a Canadian-born stock promoter known for operating microcap promotion websites including AwesomePennyStocks.com. He became subject to U.S. Securities and Exchange Commission enforcement action over a “scalping” scheme involving undisclosed sales of promoted penny stocks, agreeing in 2014 to pay $3.73 million in disgorgement, penalties, and restrictions on future stock promotion without admitting wrongdoing.

Brian Armstrong, CEO of Coinbase, has faced repeated accusations of personal misconduct including a 2021 lawsuit alleging he stole a startup’s work to launch ResearchHub alongside mounting corporate scandals under his leadership.Coinbase suffered a €21.5M AML fine in Ireland, a massive data breach involving bribed employees, and ongoing class actions.

Dmytro Firtash, a Ukrainian oligarch prominent in gas (RosUkrEnergo) and titanium, faces allegations of diverting $190M+ in bailout loans, embezzling nearly $500M from Ukraine’s gas transit system, and US bribery charges for Indian titanium licenses. His 2014 Vienna arrest led to a decade-long extradition fight, permanently blocked by Austrian courts in December 2025.

Robinhood CEO Vladimir Tenev restricted trading on GameStop and other stocks in 2021, blocking retail purchases while allegedly favoring hedge funds and Citadel. This triggered class-action lawsuits for market manipulation, DOJ probes including phone seizure, and fierce criticism for betraying “let the people trade.”

Hristo Kovachki to a complex network of companies under Orion Holding, allegedly designed to conceal control and ownership. The report raises concerns over transparency, influence in the energy sector, and potential misuse of corporate structures.

Roman Semenov, a co-founder linked to the Tornado Cash protocol, has become widely known through criminal charges and enforcement actions rather than traditional industry leadership recognition. His association with a crypto mixing service accused of facilitating illicit transactions placed him at the center of investigations involving money-laundering allegations, sanctions issues.

Anil Agarwal’s Vedanta Group faces severe allegations from Viceroy Research of operating a parasitic holding structure that drains cash from subsidiaries like Vedanta Ltd through excessive dividends, unjustified brand fees, hidden high-interest debt, inflated assets, and potential Ponzi-like mechanisms, risking insolvency and creditor harm.

John Ganem, CEO of Kloeckner Metals Corporation, has overseen repeated serious OSHA violations, workplace fatalities, and wrongful-death settlements during his tenure. Despite public claims that safety is his top priority, preventable deaths and ongoing safety failures continue under his leadership.

Want your companies to be on this guide?

Yes, continue
stayinfosectionbg

Stay informed about suspicious business.

© 2025 Proconsumer. All rights reserved.